273 related articles for article (PubMed ID: 28159123)
1. Who uses long-acting reversible contraception? Profile of LARC users in the CUPID cohort.
Coombe J; Harris ML; Loxton D
Sex Reprod Healthc; 2017 Mar; 11():19-24. PubMed ID: 28159123
[TBL] [Abstract][Full Text] [Related]
2. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study.
Harney C; Dude A; Haider S
Contraception; 2017 Mar; 95(3):245-250. PubMed ID: 27589883
[TBL] [Abstract][Full Text] [Related]
4. Unintended pregnancy and subsequent postpartum long-acting reversible contraceptive use in Zimbabwe.
Nance N; Ralph L; Padian N; Cowan F; Buzdugan R; Mushavi A; Mahomva A; McCoy SI
BMC Womens Health; 2018 Nov; 18(1):193. PubMed ID: 30477497
[TBL] [Abstract][Full Text] [Related]
5. Are Health Plan Design and Prior Use of Long-Acting Reversible Contraception Associated with Pregnancy Intention?
Armstrong MA; Postlethwaite DA; Darbinian JA; McCoy M; Law A
J Womens Health (Larchmt); 2017 May; 26(5):450-460. PubMed ID: 27753522
[TBL] [Abstract][Full Text] [Related]
6. Characteristics associated with interest in long-acting reversible contraception in a postpartum population.
Tang JH; Dominik R; Re S; Brody S; Stuart GS
Contraception; 2013 Jul; 88(1):52-7. PubMed ID: 23158805
[TBL] [Abstract][Full Text] [Related]
7. Dual method use among long-acting reversible contraceptive users.
Bernard C; Zhao Q; Peipert JF
Eur J Contracept Reprod Health Care; 2018 Apr; 23(2):97-104. PubMed ID: 29582687
[TBL] [Abstract][Full Text] [Related]
8. Motivators of contraceptive method change and implications for long-acting reversible contraception (non-)use: A qualitative free-text analysis.
Coombe J; Harris ML; Loxton D
Sex Reprod Healthc; 2019 Mar; 19():71-77. PubMed ID: 30928138
[TBL] [Abstract][Full Text] [Related]
9. Choice of Postpartum Contraception: Factors Predisposing Pregnant Adolescents to Choose Less Effective Methods Over Long-Acting Reversible Contraception.
Chacko MR; Wiemann CM; Buzi RS; Kozinetz CA; Peskin M; Smith PB
J Adolesc Health; 2016 Jun; 58(6):628-35. PubMed ID: 26852250
[TBL] [Abstract][Full Text] [Related]
10. Predictors of choosing long-acting reversible contraceptive methods when provided free-of-charge - A prospective cohort study in Finland.
Gyllenberg F; Saloranta T; But A; Gissler M; Heikinheimo O
Contraception; 2020 Jun; 101(6):370-375. PubMed ID: 32061566
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
[TBL] [Abstract][Full Text] [Related]
12. The Rise of Female Sterilization: A Closer Look at Colombia.
Folch BM; Betstadt S; Li D; Whaley N
Matern Child Health J; 2017 Sep; 21(9):1772-1777. PubMed ID: 28795311
[TBL] [Abstract][Full Text] [Related]
13. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.
Hubacher D; Spector H; Monteith C; Chen PL
Contraception; 2018 Jun; 97(6):524-532. PubMed ID: 29470950
[TBL] [Abstract][Full Text] [Related]
14. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review.
Birgisson NE; Zhao Q; Secura GM; Madden T; Peipert JF
J Womens Health (Larchmt); 2015 May; 24(5):349-53. PubMed ID: 25825986
[TBL] [Abstract][Full Text] [Related]
15. Understanding the low uptake of long-acting reversible contraception by young women in Australia: a qualitative study.
Garrett CC; Keogh LA; Kavanagh A; Tomnay J; Hocking JS
BMC Womens Health; 2015 Sep; 15():72. PubMed ID: 26359250
[TBL] [Abstract][Full Text] [Related]
16. Barriers to Receiving Long-acting Reversible Contraception in the Postpartum Period.
Zerden ML; Tang JH; Stuart GS; Norton DR; Verbiest SB; Brody S
Womens Health Issues; 2015; 25(6):616-21. PubMed ID: 26212318
[TBL] [Abstract][Full Text] [Related]
17. Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Contraception; 2015 Mar; 91(3):185-92. PubMed ID: 25500324
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Balanced Counseling on Contraceptive Method Choice and Determinants of Long Acting and Reversible Contraceptive Continuation in Nepal.
Sapkota S; Rajbhandary R; Lohani S
Matern Child Health J; 2017 Sep; 21(9):1713-1723. PubMed ID: 26955996
[TBL] [Abstract][Full Text] [Related]
19. The influence of trust in health care systems on postabortion contraceptive choice.
Stacey RE; Dempsey A
Contraception; 2015 Nov; 92(5):458-62. PubMed ID: 26197264
[TBL] [Abstract][Full Text] [Related]
20. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.
Luo Z; Gao L; Anguzu R; Zhao J
Reprod Health; 2018 May; 15(1):85. PubMed ID: 29793501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
